Estimating the impact and cost of the WHO 2010 recommendations for antiretroviral therapy

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Stover, John ^a   Bollinger, Lori ^a   Avila, Carlos ^b  

^a AVENIR HEALTH   (United States)

^b UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953758954     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/738271     Document Type: Article

References (23)

1. WHO, Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. http://www.who.int/hiv/pub/arv/adult2010/en/index.html
2. Adam M. A., Johnson L. F., Estimation of adult antiretroviral treatment coverage in South Africa. South African Medical Journal 2009 99 9 661 667 2-s2.0-70450193682
3. Stover J., Johnson P., Zaba B., Zwahlen M., Dabis F., Ekpini R. E., The spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sexually Transmitted Infections 2008 84 supplement 1 i24 i30 2-s2.0-49049107116 10.1136/sti.2008.029868
4. Auvert B., Males S., Puren A., Taljaard D., Caraël M., Williams B., Can highly active antiretroviral therapy reduce the spread of HIV?: a study in a township of South Africa. Journal of Acquired Immune Deficiency Syndromes 2004 36 1 613 621 2-s2.0-2142646425 10.1097/00126334-200405010-00010 (Pubitemid 38544511)
5. Connelly D., Veriava Y., Roberts S., Tsotetsi J., Jordan A., DeSilva E., Rosen S., DeSilva M. B., Prevalence of HIV infection and median CD4 counts among health care workers in South Africa. South African Medical Journal 2007 97 2 115 120 2-s2.0-33847109704 (Pubitemid 46291119)
6. Rehle T. M., Shisana O., Estimates of eligibility for antiretroviral treatment (ART) and projected ART impact on AIDS mortality among South African educators. Journal of Social Aspects of HIV/AIDS 2005 2 3 304 310 2-s2.0-33748451292
7. Holmes C. B., Wood R., Badri M., Zilber S., Wang B., Maartens G., Zheng H., Lu Z., Freedberg K. A., Losina E., CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. Journal of Acquired Immune Deficiency Syndromes 2006 42 4 464 469 2-s2.0-33745899037 10.1097/01.qai.0000225729.79610.b7 (Pubitemid 44050895)
8. McGrath N., Kranzer K., Saul J., Crampin A. C., Malema S., Kachiwanda L., Zaba B., Jahn A., Fine P. E. M., Glynn J. R., Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS 2007 21 supplement 6 S105 S113 2-s2.0-36349015384 10.1097/01.aids.0000299417.69432.65 (Pubitemid 350158895)
9. National AIDS, STI Control Programme, Ministry of Health, Kenya AIDS Indicator Survey 2007: Preliminary Report 2008 Nairobi, Kenya National AIDS and STI Control Programme, Ministry of Health
10. Todd J., Glynn J. R., Marston M., Lutalo T., Biraro S., Mwita W., Suriyanon V., Rangsin R., Nelson K. E., Sonnenberg P., Fitzgerald D., Karita E., Zaba B., Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007 21 supplement 6 S55 S63 2-s2.0-36349006369 10.1097/01.aids.0000279707.01557.b2
11. WHO, Futures Institute, UNAIDS, Antiretroviral medicines in low- and middle- income countries: usage in 2008 and a demand forecast for 2010-2012 with a special focus on sub-Saharan Africa. Forthcoming, 2010
12. Bautista S. A., Dmytraczenko T., Kombe G., Bertozzi S. M., Costing of HIV/AIDS treatment in Mexico. PHRPlus Report June 2003
13. Chandler R., Musau R., Estimating resource requirements for scaling up antiretroviral therapy in Uganda. PHRPlus Paper October 2005
14. Cleary S. M., scleary@heu.uct.ac.za McIntyre D., dimac@heu.uct.ac.za Boulle A. M., aboulle@phfm.uct.ac.za The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa-a primary data analysis. Cost Effectiveness and Resource Allocation 2006 4, article 20 10.1186/1478-7547-4-20 (Pubitemid 46189708)
15. Goldie S. J., sue-goldie@harvard.edu Yazdanpanah Y., Losina E., Weinstein M. C., Anglaret X., Walensky R. P., Hsu H. E., Kimmel A., Holmes C., Kaplan J. E., Freedberg K. A., Cost-effectiveness of HIV treatment in resource-poor settings-the case of Côte d'Ivoire. New England Journal of Medicine 2006 355 11 1141 1153 10.1056/NEJMsa060247 (Pubitemid 44394920)
16. Huddart J., Furth R., Lyons J. V., The Zambia Workforce Study: Preparing for Scale-up. April 2004, http://www.qaproject.org
17. Kitajima T., kitajima@kyorin-u.ac.jp Kobayashi Y., Chaipah W., Sato H., Chadbunchachai W., Thuennadee R., Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand. AIDS 2003 17 16 2375 2381 10.1097/00002030- 200311070-00013 (Pubitemid 38147024)
18. Kombe G., Galaty D., Gadhia R., Decker C., The Human and Financial Resource Requiremens for Scaling Up HIV/AID Services in Ethiopia. PHRPlus, February 2005
19. Kombe G., Smith O., The costs of anti-retroviral treatment in Zambia. PHRPlus Project October 2003
20. PHRPlus, Rapid Assessment of HIV/AIDS Care in the Public and Private Sectors. PHRPlus, Nigeria, August 2004
21. Badri M., motasim.badri@hiv-research.org.za Maartens G., Mandalia S., Bekker L.-G., Penrod J. R., Platt R. W., Wood R., Beck E. J., Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Medicine 2006 3 1, article e4 48 56 10.1371/journal.pmed.0030004 (Pubitemid 43204370)
22. WHO, WHO-CHOICE database. June 2010, http://www.who.int/choice/costs/en
23. UNAIDS, Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support. February 2009, http://data.unaids.org/ pub/Report/2007/jc1678-fin-res-req-en.pdf